Quantcast
Last updated on April 23, 2014 at 21:24 EDT

Latest Mount Sinai Stories

2014-04-16 23:01:31

Researchers from Mount Sinai Demonstrate Proof of Concept for New, Rapidly-Acting Pharmacotherapy for Treatment of PTSD New York, NY (PRWEB) April 16, 2014 For the first time, evidence that a single dose of IV-administered ketamine was associated with the rapid reduction of symptoms of post-traumatic stress disorder in patients with chronic PTSD was demonstrated in a proof-of-concept, randomized, double blind crossover study, undertaken by researchers at the Icahn School of Medicine at...

2014-04-15 23:08:27

Cardiologists and cancer experts at The Mount Sinai Hospital have joined forces to establish its first Cardio-Oncology Clinic at The Tisch Cancer Institute at The Mount Sinai Hospital. New York, NY (PRWEB) April 15, 2014 Cardiologists and cancer experts at The Mount Sinai Hospital have joined forces to establish its first Cardio-Oncology Clinic at The Tisch Cancer Institute at The Mount Sinai Hospital. The Cardio-Oncology Clinic, located at the Leon and Norma Hess Center for Science and...

2014-04-14 23:05:57

Six Mount Sinai Expert Guides use apps and digital content to support a new generation of physicians New York (PRWEB) April 14, 2014 Wiley has teamed up with the Icahn School of Medicine at Mount Sinai, one of the world's leading medical institutions, to create a series of expert guides for medical trainees, research fellows and practicing physicians. The six Mount Sinai Expert Guides combine the expertise of the medical faculty with new online platforms and mobile apps, creating...

2014-04-08 23:02:24

Mount Sinai Team Cautiously Optimistic That Door Could Swing Open to A New Antidepressant Drug Class New York, NY (PRWEB) April 08, 2014 A research team from the Icahn School of Medicine at Mount Sinai published the first controlled evidence showing that an intranasal ketamine spray conferred an unusually rapid antidepressant effect –within 24 hours—and was well tolerated in patients with treatment-resistant major depressive disorder. This is the first study to show benefits with an...

2014-03-20 23:01:18

Icahn School of Medicine at Mount Sinai Reports 9/11 Linked to Two Heart Disease Culprits: Obstructive Sleep Apnea and Post-Traumatic Stress Disorder New York, NY (PRWEB) March 20, 2014 Icahn School of Medicine at Mount Sinai researchers have linked high levels of exposure to inhaled particulate matter by first responders at Ground Zero to the risk of obstructed sleep apnea and post-traumatic stress disorder (PTSD), both conditions that may impact cardiovascular health. The two separate...

2014-03-13 23:02:55

Study Suggests Targeting Molecular Interaction of Virus and Host Protein May Arrest This Lethal Virus New York, NY (PRWEB) March 13, 2014 A protein that normally protects cells from environmental stresses has been shown to interact Marburg virus VP24, allowing the deadly Marburg virus to live longer and replicate better, according to a preclinical study led by scientists at the Icahn School of Medicine at Mount Sinai. The investigators say that deciphering the molecular details of how...

2014-03-12 23:02:34

Collaborative Research Study by Icahn School of Medicine at Mount Sinai, Sanford-Burnham Medical Research Institute, and University of California, San Diego, Shows Blocking microRNA miR-25 Halts Progression of Heart Failure, Improves Cardiac Function, and May Increase Survival New York, NY (PRWEB) March 12, 2014 A team of cardiovascular researchers from the Cardiovascular Research Center at Icahn School of Medicine at Mount Sinai, Sanford-Burnham Medical Research Institute, and University...

2014-02-28 23:26:13

Icahn School of Medicine at Mount Sinai study suggests early-stage atherosclerosis is reversible, and identifies new genetic targets for fighting advanced atherosclerosis New York, NY (PRWEB) February 28, 2014 Research at Icahn School of Medicine at Mount Sinai has led to important new discoveries about the process behind regression of atherosclerosis, the main underlying cause of heart attack and stroke. In the paper published today in PLoS Genetics, scientists from Mount Sinai and the...

2014-02-25 14:13:52

RGS-9-2 protein affects not only addiction, but analgesic relief and tolerance Identifying the specific pathways that promote opioid addiction, pain relief, and tolerance are crucial for developing more effective and less dangerous analgesics, as well as developing new treatments for addiction. Now, new research from the Icahn School of Medicine at Mount Sinai reveals that opiate use alters the activity of a specific protein needed for the normal functioning of the brain's reward center....

2014-02-24 23:04:11

Modifying Dietary Intake of Advanced Glycation Endproducts, or AGEs, Bolsters Body’s Defenses Against Alzheimer’s and Metabolic Syndrome, Say Mount Sinai Researchers New York, NY (PRWEB) February 24, 2014 Advanced glycation endproducts, or AGEs, are compounds commonly found in the so-called “Western diet,” and previously have been linked to increased body weight, diabetes, and possibly Alzheimer’s disease. Now, researchers at the Icahn School of Medicine at Mount Sinai have...